SLCO4A1-AS1 promotes cell growth and induces resistance in lung adenocarcinoma by modulating miR-4701-5p/NFE2L1 axis

Yuxuan Wei1, Li Wei2, Jiwei Li2

  • 1Lanzhou University Second Hospital, Lanzhou University Second Clinical Medical College, Lanzhou, China.

Cancer Medicine
|August 8, 2020
PubMed

Insights

Long noncoding RNA SLCO4A1-AS1 promotes lung adenocarcinoma (LUAD) growth and chemoresistance. It activates the WNT pathway by interacting with miR-4701-5p and targeting NFE2L1, driving LUAD progression.

Area of Science:

  • Molecular Biology
  • Oncology
  • Gene Regulation

Background:

  • Long noncoding RNAs (lncRNAs) play crucial roles in human cancer development.
  • SLCO4A1 antisense RNA 1 (SLCO4A1-AS1) is implicated as an oncogenic regulator in other cancers, but its role in lung adenocarcinoma (LUAD) is unknown.

Purpose of the Study:

  • To investigate the function and mechanism of SLCO4A1-AS1 in lung adenocarcinoma (LUAD).
  • To explore the potential of SLCO4A1-AS1 as a therapeutic target in LUAD.

Main Methods:

  • Quantitative real-time PCR to assess SLCO4A1-AS1 expression levels in LUAD tissues and cells.
  • In vitro functional assays (proliferation, migration, cisplatin resistance) to evaluate the impact of SLCO4A1-AS1.
  • Mechanism studies including RNA immunoprecipitation, luciferase reporter assays, and Western blotting to elucidate the interaction between SLCO4A1-AS1, miR-4701-5p, and NFE2L1.
  • Rescue experiments to confirm the role of NFE2L1 in SLCO4A1-AS1-mediated effects.

Main Results:

  • SLCO4A1-AS1 was significantly upregulated in LUAD tissues and cells.
  • SLCO4A1-AS1 overexpression promoted LUAD cell proliferation, migration, and cisplatin resistance.
  • SLCO4A1-AS1 interacted with miR-4701-5p, which directly targeted NFE2L1.
  • NFE2L1 expression was positively correlated with SLCO4A1-AS1 and involved in SLCO4A1-AS1-induced LUAD cell growth via WNT pathway activation.

Conclusions:

  • SLCO4A1-AS1 acts as an oncogene in LUAD by promoting cell growth and chemoresistance.
  • The SLCO4A1-AS1/miR-4701-5p/NFE2L1 axis, involving WNT pathway activation, is a key mechanism driving LUAD progression.
  • SLCO4A1-AS1 represents a potential therapeutic target for lung adenocarcinoma.

Related Concept Videos

lncRNA - Long Non-coding RNAs02:39

lncRNA - Long Non-coding RNAs

In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
9.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.0K
Canonical Wnt Signaling Pathway02:54

Canonical Wnt Signaling Pathway

The gene encoding the main signaling molecules of the Wnt signaling pathways (the Wnt proteins) was discovered almost four decades ago by Nüsslein-Volhard and Wieschaus. They identified and originally named the gene "wingless" (wg) after a phenotype discovered during their landmark genetic screen in Drosophila for body pattern defects. At around the same time, another researcher named Harold Varmus found that a murine tumor virus activates the mammalian wg homolog, Int-1, which...
10.1K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
4.5K